002800.KQ Sinsin Pharmaceutical Co. Ltd

Healthcare Oil, Gas & Consumable Fuels KOSDAQ
3,975 KRW
Close of Nov 1, 2026
3,900 6,917
Market cap
KRW 60.3B
P/E
4.5x
P/B
0.76x
ROE
16.6%
Dividend yield
1.51%
Fundamental score
3.8/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 002800.KQ undervalued?

Graham number
Price3,975
Graham value10,129
Discount60.8%

002800.KQ trades 60.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sinsin Pharmaceutical Co. Ltd fundamental analysis

20 of 22 checks passed

ROE 1/2

Moderate return on equity (16.6%), between 10% and 20%.

ROA 1/1

Return on assets (9.3%) is above the industry median (1.4%).

Profit Consistency 1/2

Profitable for 4 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (90.1%) is not above the 5-year average (91.3% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (90.1%) is above the industry median (1.8%).

Revenue Growth 1/2

Revenue grew 7.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (0.8%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 11.9x against interest expense, well covered.

PE vs Market 1/1

PE (4.5x) is below the market median (11.3x).

PE vs Industry 1/1

PE (4.5x) is below the industry median (11.4x).

PBV 1/1

Price to book (0.8x) is below the industry median (0.9x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 3.5, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.05, growth is cheap.

Dividend Yield 1/2

Dividend yield (1.5%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 9.8%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Sinsin Pharmaceutical Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sinsin Pharmaceutical Co. Ltd

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, …

Full company profile